Sandwich assay for carcinoembryonic antigen with immobilized lectins and a monoclonal antibody

A Nagata1, M Miura, T Komoda

  • 1Department of Biochemistry, Saitama Medical School, Moroyama, Japan.

Insights

A new lectin-linked immunoradiometric assay (L-IRMA) effectively detects carcinoembryonic antigen (CEA) by analyzing sugar chain structures. This method offers a simple approach to study glycoprotein heterogeneity in various subjects.

Area of Science:

  • Biochemistry
  • Immunology
  • Glycobiology

Background:

  • Carcinoembryonic antigen (CEA) is a tumor marker with heterogeneous glycosylation.
  • Understanding CEA glycosylation is crucial for cancer diagnostics and research.
  • Existing methods for analyzing glycoprotein heterogeneity can be complex.

Purpose of the Study:

  • To develop a simple and effective assay for detecting carcinoembryonic antigen (CEA) variants.
  • To characterize the sugar chain structures of CEA using lectin-based methods.
  • To investigate glycoprotein heterogeneity in tumors and normal tissues.

Main Methods:

  • Development of a lectin-linked immunoradiometric assay (L-IRMA).
  • Utilized seven different lectins and a monoclonal antibody (MoAb) targeting CEA.
  • Quantified bound 125I-labeled anti-CEA MoAb after CEA binding to lectin agarose beads.

Main Results:

  • L-IRMA successfully detected CEA and differentiated sugar chain types.
  • Specific lectin interactions indicated complex and hybrid sugar chains in CEA.
  • Results correlated well with traditional lectin affinity chromatography.

Conclusions:

  • L-IRMA provides a straightforward method for assessing CEA glycoprotein heterogeneity.
  • This assay can aid in studying glycosylation differences in neoplastic and normal tissues.
  • The findings contribute to a better understanding of CEA's role in disease states.